Search

Your search keyword '"Cabero Martínez, A."' showing total 29 results
Start Over Author "Cabero Martínez, A."
29 results on '"Cabero Martínez, A."'

1. P1320: INCIDENCE AND IMPACT OF COMPLICATIONS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN PATIENTS OVER 60 YEARS. RETROSPECTIVE EXPERIENCE OF TWO SPANISH CENTERS IN THE 2015-2020 PERIOD

Author

M. Baile, M. Hidalgo Soto, S. Marcos Asensio, M. Cabrero Calvo, R. Martínez Fernández, A. Avendaño Pita, A. Á. Martín López, A. Cabero Martínez, M. Cortés Rodríguez, E. Pérez López, L. López Corral, F. Sánchez Guijo, L. Vázquez López, and M. D. Caballero Barrigón

Subjects
Diseases of the blood and blood-forming organs, RC633-647.5
Published
2022
Full Text
View/download PDF

2. P1321: INCIDENCE AND IMPACT OF GRAFT-VERSUS-HOST DISEASE (GVHD) IN PATIENTS OVER 60 YEARS OF AGE UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT). RETROSPECTIVE EXPERIENCE OF TWO SPANISH CENTERS

Author

M. Baile, M. Hidalgo Soto, S. Marcos Asensio, M. Cabrero Calvo, R. Martínez Fernández, A. Avendaño Pita, A. Á. Martín López, A. Cabero Martínez, M. Cortés Rodríguez, E. Pérez López, L. López Corral, F. Sánchez Guijo, L. Vázquez López, and M. D. Caballero Barrigón

Subjects
Diseases of the blood and blood-forming organs, RC633-647.5
Published
2022
Full Text
View/download PDF

3. P1322: ALLOGENEIC HEMATOPOIETIC STEM TRANSPLANTATION (HSCT) IN PATIENTS OVER 60 YEARS. RETROSPECTIVE EXPERIENCE OF TWO SPANISH CENTERS BETWEEN 2015-2020

Author

M. Baile González, M. Hidalgo Soto, S. Marcos Asensio, M. Cabrero Calvo, R. Martínez Fernández, A. Avendaño Pita, A. Á. Martín López, A. Cabero Martínez, M. Cortés Rodríguez, E. Pérez López, L. López Corral, F. Sánchez Guijo, L. Vázquez López, and M. D. Caballero Barrigón

Subjects
Diseases of the blood and blood-forming organs, RC633-647.5
Published
2022
Full Text
View/download PDF

5. Measures to Maintain a SARS-CoV-2 Negative Inpatient Hematological Unit in the Midst of the COVID-19 Pandemic

Author

Almudena Cabero-Martínez, Fermín Sánchez-Guijo, Lucía López-Corral, Estefanía Pérez, Alejandro Avendaño, Mónica Baile, Mónica Cabrero, Ana-Africa Martín, Angela Rodríguez, Balbina Pérez, Felipe Peña-Muñoz, Luz-Gema Román, Danylo Palomino, Lourdes López-Vázquez, María-Belén Vidriales, Marcos González-Diaz, María-Victoria Mateos, and María-Dolores Caballero

Subjects
COVID-19, hematology, preventive measurements, inpatient units, immunodepressed patients, pandemic (COVID-19), Medicine (General), R5-920
Abstract

The University Hospital of Salamanca, in Spain, had its first COVID-19 case on March 1st and as of May 11th, we had 1,100 positive cases. Based on the vulnerability of patients with blood cancers, on March 9th, the Hematology Department developed a protocol, amended as the new information was available, to maintain the Hematology Unit as a “free COVID-19 island.” The protocol included symptom-based surveys and screening tests to patients, caregivers, and healthcare personnel to identify early potential positive cases and prevent its spread. Between March 9 and April 28, 32 asymptomatic patients and caregivers were tested and 68 rT-PCR diagnostic assays have been performed with two positive results. A 106 healthcare workers have been tested (208 rT-PCR) and seven of them were positive. In summary, the implementation of preemptive measures after the first case appeared allowed us to be able to provide treatment to our patients.

Published
2020
Full Text
View/download PDF

6. FACTORS INFLUENCING SURVIVAL AND PROLONGED VIRAL REPLICATION IN PATIENTS WITH LYMPHOMA AND COVID‐19: AN OBSERVATIONAL COHORT STUDY FROM GELTAMO SPANISH GROUP

Author

Cabero‐Martínez, A., primary, Bastos‐Oreiro, M., additional, López‐García, A., additional, Baile, M., additional, Franch, M., additional, Llacer‐Ferrandis, M. J., additional, Izuzquiza, M., additional, Jiménez‐Ubieto, A., additional, Escoda, L., additional, Nistal, S., additional, González‐Barca, E., additional, García‐Belmonte, D., additional, Hernández‐Mohedo, F., additional, Sánchez‐González, B., additional, Martin‐Martitegui, X., additional, Arguiñano, J. M., additional, Ramirez‐Payer, A., additional, Roldan‐Perez, A., additional, Zeberio, I., additional, Diaz‐Galvez, J., additional, Cannata‐Ortiz, J., additional, Peñarrubia, M. J., additional, Campo, R. del, additional, Luzardo, H., additional, Solé‐Rodríguez, M., additional, Lorente, S., additional, Muntañola, A., additional, Alonso‐Prieto, C., additional, Yamil, G., additional, Villafuerte, P., additional, Guillen‐Garcia, H., additional, Gómez‐Roncero, M. I., additional, Infante, M. S., additional, Peñalver, F. J., additional, Cortés, M., additional, Abrisqueta, P., additional, Córdoba, R., additional, Sancho, J. M., additional, and García‐Sancho, A. Martin, additional

Published
2023
Full Text
View/download PDF

7. Rituximab Maintenance after R-Bendamustine or R-CHOP in First-Line Treatment of Low-Grade Follicular Lymphoma: A Multicentre, Retrospective Study of the Spanih Group Geltamo

Author

Bastos-Oreiro, Mariana, primary, Gutierrez, Antonio, additional, Cabero Martínez, Almudena, additional, López Jiménez, Javier, additional, Villafuerte Gutierrez, Paola Sandra, additional, Jimenez-Ubieto, Ana, additional, De La Fuente, Adolfo, additional, Navarro, Belén, additional, Infante, Maria Stefania, additional, Cordoba, Raul, additional, Perez De Oteyza, Jaime, additional, González de Villambrosia, Sonia, additional, Del Campo, Raquel, additional, Garcia, Daniel, additional, Salar, Antonio, additional, and Sancho, Juan-Manuel, additional

Published
2022
Full Text
View/download PDF

8. Poster: ABCL-297 Hemophagocytic Lymphohistiocytosis Singularity: A Multicenter Retrospective Study

Author

Hernández-Sánchez, Alberto, primary, Cerezo-Martín, Juan Manuel, additional, García-Bacelar, Ana, additional, Caballero-Álvarez, Daniela, additional, Azibeiro, Raúl, additional, Pablos, Alicia, additional, Gómez-Úbeda, Sandra, additional, Puertas, Borja, additional, Baile, Mónica, additional, Avendaño, Alejandro, additional, Cabrero, Mónica, additional, López-Cadenas, Félix, additional, Caballero, Dolores, additional, López-Corral, Lucía, additional, and Cabero-Martínez, Almudena, additional

Published
2022
Full Text
View/download PDF

9. Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study.

Author

Gros, Luis, Roldán, Alicia, Cabero-Martínez, Almudena, Domínguez-Pinilla, Nerea, de la Fuente, Adolfo, González-Barca, Eva, Tasso, María, Torrent, Montserrat, Gallardo, Eva, del Cerro, Inés, Giró-Perafita, Ariadna, and Badia, Xavier

Subjects
HOSPITALS, FOLINIC acid, METHOTREXATE, QUESTIONNAIRES, DESCRIPTIVE statistics, IMMUNOENZYME technique, RESEARCH funding, HEMODIALYSIS, DATA analysis software, ACUTE kidney failure, DELPHI method, BLOOD filtration
Abstract

Introduction: High-dose methotrexate (HDMTX) is administered for the treatment of some cancers. HDMTX is usually safe but may crystallize in renal tubules causing acute kidney injury (AKI). Consequently, MTX elimination is delayed, resulting in a severe and life-threatening condition. No studies have been published about the impact of MTX toxicity in Spain. This study aims to estimate the incidence and management of MTX delayed elimination and toxicity. Methods: A two-round Delphi study was performed to reach consensus between 10 medical experts on haemato-oncology and paediatric oncology with experience in the management of HDMTX treated patients from leading Spanish hospitals. An online questionnaire was developed based on national and international guidelines and previous evidence regarding HDMTX-related toxicity. Consensus was established at 80% agreement. Median and interquartile ranges were calculated, and incidence data were extrapolated to the Spanish general population. Results: Out of 1.475 patients estimated to receive HDMTX treatment annually in Spain, 27.5% present MTX delayed elimination and 11.6% develop HDMTX-induced AKI (35.4% with severe systemic toxicities (>grade 3) and 18.8% develop chronic renal disease). Mortality is estimated in 4.2%. Immuno-enzymatic assay is used in most of the hospitals (90%) for MTX serum level monitoring. All experts use increased supportive care and high leucovorin as first-line treatment. Available treatments in experts' hospitals in case toxicity persists are haemodialysis (90% of hospitals), glucarpidase (60%) and hemofiltration (50%). Most prevalent non-renal systemic toxicities are haematologic and mucositis (21–40% of patients). Patients with HDMTX-induced AKI require from intensive care (5% of patients), more than 3 sessions and 4 days of dialysis, and about 8.5 days of hospitalization (non-ICU patients) and 12 days in case of patients requiring ICU. Conclusions: These results are the first evidence regarding HDMTX-induced AKI in Spain. Incidence and mortality results are in line with previous studies. Clinical management is based on preventive measures and the treatment depend on the availability in the hospital. The need for effective, safe and rapid treatment for the reduction of MTX toxic levels and the improvement of monitoring methods were noted by experts as urgent needs. Further observational studies to validate these results would be needed. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

10. P1320: INCIDENCE AND IMPACT OF COMPLICATIONS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN PATIENTS OVER 60 YEARS. RETROSPECTIVE EXPERIENCE OF TWO SPANISH CENTERS IN THE 2015-2020 PERIOD

Author

Baile, M., primary, Hidalgo Soto, M., additional, Marcos Asensio, S., additional, Cabrero Calvo, M., additional, Martínez Fernández, R., additional, Avendaño Pita, A., additional, Martín López, A. Á., additional, Cabero Martínez, A., additional, Cortés Rodríguez, M., additional, Pérez López, E., additional, López Corral, L., additional, Sánchez Guijo, F., additional, Vázquez López, L., additional, and Caballero Barrigón, M. D., additional

Published
2022
Full Text
View/download PDF

11. P1321: INCIDENCE AND IMPACT OF GRAFT-VERSUS-HOST DISEASE (GVHD) IN PATIENTS OVER 60 YEARS OF AGE UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT). RETROSPECTIVE EXPERIENCE OF TWO SPANISH CENTERS

Author

Baile, M., primary, Hidalgo Soto, M., additional, Marcos Asensio, S., additional, Cabrero Calvo, M., additional, Martínez Fernández, R., additional, Avendaño Pita, A., additional, Martín López, A. Á., additional, Cabero Martínez, A., additional, Cortés Rodríguez, M., additional, Pérez López, E., additional, López Corral, L., additional, Sánchez Guijo, F., additional, Vázquez López, L., additional, and Caballero Barrigón, M. D., additional

Published
2022
Full Text
View/download PDF

12. P1322: ALLOGENEIC HEMATOPOIETIC STEM TRANSPLANTATION (HSCT) IN PATIENTS OVER 60 YEARS. RETROSPECTIVE EXPERIENCE OF TWO SPANISH CENTERS BETWEEN 2015-2020

Author

Baile González, M., primary, Hidalgo Soto, M., additional, Marcos Asensio, S., additional, Cabrero Calvo, M., additional, Martínez Fernández, R., additional, Avendaño Pita, A., additional, Martín López, A. Á., additional, Cabero Martínez, A., additional, Cortés Rodríguez, M., additional, Pérez López, E., additional, López Corral, L., additional, Sánchez Guijo, F., additional, Vázquez López, L., additional, and Caballero Barrigón, M. D., additional

Published
2022
Full Text
View/download PDF

13. Rituximab Maintenance after R-Bendamustine or R-CHOP in First-Line Treatment of Low-Grade Follicular Lymphoma: A Multicentre, Retrospective Study of the Spanih Group Geltamo

Author

Mariana Bastos-Oreiro, Antonio Gutierrez, Almudena Cabero Martínez, Javier López Jiménez, Paola Sandra Villafuerte Gutierrez, Ana Jimenez-Ubieto, Adolfo De La Fuente, Belén Navarro, Maria Stefania Infante, Raul Cordoba, Jaime Perez De Oteyza, Sonia González de Villambrosia, Raquel Del Campo, Daniel Garcia, Antonio Salar, and Juan-Manuel Sancho

Subjects
Immunology, Cell Biology, Hematology, Biochemistry
Published
2022

14. ABCL-297 Hemophagocytic Lymphohistiocytosis Singularity: A Multicenter Retrospective Study

Author

Alberto Hernández-Sánchez, Juan Manuel Cerezo-Martín, Ana García-Bacelar, Daniela Caballero-Álvarez, Raúl Azibeiro, Alicia Pablos, Sandra Gómez-Úbeda, Borja Puertas, Mónica Baile, Alejandro Avendaño, Mónica Cabrero, Félix López-Cadenas, Dolores Caballero, Lucía López-Corral, and Almudena Cabero-Martínez

Subjects
Cancer Research, Oncology, Hematology
Published
2022

15. Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study

Author

Luis Gros, Alicia Roldán, Almudena Cabero-Martínez, Nerea Domínguez-Pinilla, Adolfo de la Fuente, Eva González-Barca, María Tasso, Montserrat Torrent, Eva Gallardo, Inés del Cerro, Ariadna Giró-Perafita, and Xavier Badia

Subjects
Oncology, High-dose methotrexate, acute kidney injury, clinical management, Pharmacology (medical), epidemiology, methotrexate delayed elimination
Abstract

Introduction High-dose methotrexate (HDMTX) is administered for the treatment of some cancers. HDMTX is usually safe but may crystallize in renal tubules causing acute kidney injury (AKI). Consequently, MTX elimination is delayed, resulting in a severe and life-threatening condition. No studies have been published about the impact of MTX toxicity in Spain. This study aims to estimate the incidence and management of MTX delayed elimination and toxicity. Methods A two-round Delphi study was performed to reach consensus between 10 medical experts on haemato-oncology and paediatric oncology with experience in the management of HDMTX treated patients from leading Spanish hospitals. An online questionnaire was developed based on national and international guidelines and previous evidence regarding HDMTX-related toxicity. Consensus was established at 80% agreement. Median and interquartile ranges were calculated, and incidence data were extrapolated to the Spanish general population. Results Out of 1.475 patients estimated to receive HDMTX treatment annually in Spain, 27.5% present MTX delayed elimination and 11.6% develop HDMTX-induced AKI (35.4% with severe systemic toxicities (>grade 3) and 18.8% develop chronic renal disease). Mortality is estimated in 4.2%. Immuno-enzymatic assay is used in most of the hospitals (90%) for MTX serum level monitoring. All experts use increased supportive care and high leucovorin as first-line treatment. Available treatments in experts’ hospitals in case toxicity persists are haemodialysis (90% of hospitals), glucarpidase (60%) and hemofiltration (50%). Most prevalent non-renal systemic toxicities are haematologic and mucositis (21–40% of patients). Patients with HDMTX-induced AKI require from intensive care (5% of patients), more than 3 sessions and 4 days of dialysis, and about 8.5 days of hospitalization (non-ICU patients) and 12 days in case of patients requiring ICU. Conclusions These results are the first evidence regarding HDMTX-induced AKI in Spain. Incidence and mortality results are in line with previous studies. Clinical management is based on preventive measures and the treatment depend on the availability in the hospital. The need for effective, safe and rapid treatment for the reduction of MTX toxic levels and the improvement of monitoring methods were noted by experts as urgent needs. Further observational studies to validate these results would be needed.

Published
2022

16. Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study

Author

Gros, Luis, primary, Roldán, Alicia, additional, Cabero-Martínez, Almudena, additional, Domínguez-Pinilla, Nerea, additional, de la Fuente, Adolfo, additional, González-Barca, Eva, additional, Tasso, María, additional, Torrent, Montserrat, additional, Gallardo, Eva, additional, del Cerro, Inés, additional, Giró-Perafita, Ariadna, additional, and Badia, Xavier, additional

Published
2022
Full Text
View/download PDF

17. Poster: ABCL-297 Hemophagocytic Lymphohistiocytosis Singularity: A Multicenter Retrospective Study

Author

Alberto Hernández-Sánchez, Juan Manuel Cerezo-Martín, Ana García-Bacelar, Daniela Caballero-Álvarez, Raúl Azibeiro, Alicia Pablos, Sandra Gómez-Úbeda, Borja Puertas, Mónica Baile, Alejandro Avendaño, Mónica Cabrero, Félix López-Cadenas, Dolores Caballero, Lucía López-Corral, and Almudena Cabero-Martínez

Subjects
Cancer Research, Oncology, Hematology
Published
2022

18. Poster: MM-293: Early Relapse After Autologous Stem Cell Transplant in Multiple Myeloma: Single-Center Experience in Salamanca, Spain

Author

Peña-Muñoz, Felipe, primary, Román-Molano, Luz, additional, Palomino-Mendoza, Danylo, additional, Hernández-Sánchez, Alberto, additional, Puertas-Martínez, Borja, additional, Gómez-Úbeda, Sandra, additional, Baile-González, Mónica, additional, Cabero-Martínez, Almudena, additional, Avendaño-Pita, Alejandro, additional, Asensio, Sara Marcos, additional, Calle, Verónica González-de la, additional, Puig-Moron, Noemi, additional, and Mateos-Manteca, María Victoria, additional

Published
2021
Full Text
View/download PDF

19. MM-293: Early Relapse After Autologous Stem Cell Transplant in Multiple Myeloma: Single-Center Experience in Salamanca, Spain

Author

Peña-Muñoz, Felipe, primary, Román-Molano, Luz, additional, Palomino-Mendoza, Danylo, additional, Hernández-Sánchez, Alberto, additional, Puertas-Martínez, Borja, additional, Gómez-Úbeda, Sandra, additional, Baile-González, Mónica, additional, Cabero-Martínez, Almudena, additional, Avendaño-Pita, Alejandro, additional, Asensio, Sara Marcos, additional, la Calle, Verónica González-de, additional, Puig-Moron, Noemi, additional, and Mateos-Manteca, María Victoria, additional

Published
2021
Full Text
View/download PDF

20. Graft Versus Host Disease Prophylaxis with Tacrolimus, Sirolimus and MMF in Patients Undergoing Reduced Intensity Conditioning Allogeneic Transplantation

Author

Lopez Corral, Lucia, Blázquez Goñi, Cristina, Pérez López, Estefanía, Martín Domínguez, Francisco Manuel, Cabero Martínez, Almudena, Rodríguez Torres, Nancy, Cabrero Calvo, Monica, Espigado, Ildefonso, Martin Lopez, Ana Africa, Parody, Rocio, Baile González, Mónica, Caballero, Teresa, Cortés-Rodríguez, María, Soria Saldise, Elena, Avendaño Pita, Alejandro, Alcalde Mellado, Patricia, García Bacelar, Ana, Rodriguez Arboli, Eduardo, Lopez Parra, Miriam, Falantes, Jose Francisco, Navarro Bailon, Almudena, Vázquez López, Lourdes, Escamilla Gomez, Virginia, Sanchez-Guijo Martin, Fermin, and Pérez-Simón, Jose A.

Published
2023
Full Text
View/download PDF

21. Early Identification of Very High Risk Patients with Diffuse Large B Cell Lymphoma (DLBCL) By PET-CT

Author

Cabero Martínez, Almudena, Diaz Gonzalez, Luis Gonzaga, Montes, Carlos, Cortés-Rodríguez, María, Gutierrez, Norma C., Baile Gonzalez, Monica, García Bacelar, Ana, Lopez Parra, Miriam, Cañadas, Jose Cristobal, Villanueva, Juan Gabriel, Diaz Galvez, Francisco Javier, Peñarrubia-Ponce, María, Fernandez Ferrero, Silvia Maria, Queizan Hernandez, Jose Antonio, Cabezudo, Miguel, De Cabo López, Erik, Villaescusa, Teresa, Tamayo, Pilar, Garcia-Sanz, Ramon, and Martin García-Sancho, Alejandro

Published
2023
Full Text
View/download PDF

22. Measures to Maintain a SARS-CoV-2 Negative Inpatient Hematological Unit in the Midst of the COVID-19 Pandemic

Author

Lucía López-Corral, Felipe Peña-Muñoz, Fermín Sánchez-Guijo, M. D. Caballero, Almudena Cabero-Martínez, Mónica Baile, Luz-Gema Román, Marcos González-Díaz, Maria-Victoria Mateos, María-Belén Vidriales, Ángela López Rodríguez, Lourdes López-Vázquez, Danylo Palomino, Estefania Perez, M. Cabrero, A. Martín, Balbina Pérez, and Alejandro Avendaño

Subjects
medicine.medical_specialty, Inpatient units, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Preventive measurements, 01 natural sciences, Asymptomatic, Unit (housing), 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Health care, Pandemic, medicine, 030212 general & internal medicine, 0101 mathematics, Original Research, lcsh:R5-920, Hematology, business.industry, 010102 general mathematics, COVID-19, Immunodepressed patients, General Medicine, University hospital, pandemic (COVID-19), Emergency medicine, Medicine, medicine.symptom, lcsh:Medicine (General), business
Abstract

The University Hospital of Salamanca, in Spain, had its first COVID-19 case on March 1st and as of May 11th, we had 1,100 positive cases. Based on the vulnerability of patients with blood cancers, on March 9th, the Hematology Department developed a protocol, amended as the new information was available, to maintain the Hematology Unit as a “free COVID-19 island.” The protocol included symptom-based surveys and screening tests to patients, caregivers, and healthcare personnel to identify early potential positive cases and prevent its spread. Between March 9 and April 28, 32 asymptomatic patients and caregivers were tested and 68 rT-PCR diagnostic assays have been performed with two positive results. A 106 healthcare workers have been tested (208 rT-PCR) and seven of them were positive. In summary, the implementation of preemptive measures after the first case appeared allowed us to be able to provide treatment to our patients.

Published
2020

23. Measures to maintain a SARS-CoV-2 negative inpatient hematological unit in the midst of the COVID-19 pandemic

Author

Cabero-Martínez, Almudena, Sánchez-Guijo, Fermín M., López-Corral, L., Pérez-López, Estefanía, Avendaño, Alejandro, Baile, Mónica, Cabrero, Mónica, Martín, Ana-África, Rodríguez, Ángela, Pérez, Balbina, Peña-Muñoz, Felipe, Román, Luz-Gema, Palomino, Danylo, López-Vázquez, Lourdes, Vidriales, Maria Belén, González, Marcos, Mateos, Maria Victoria, Caballero, Maria Dolores, Cabero-Martínez, Almudena, Sánchez-Guijo, Fermín M., López-Corral, L., Pérez-López, Estefanía, Avendaño, Alejandro, Baile, Mónica, Cabrero, Mónica, Martín, Ana-África, Rodríguez, Ángela, Pérez, Balbina, Peña-Muñoz, Felipe, Román, Luz-Gema, Palomino, Danylo, López-Vázquez, Lourdes, Vidriales, Maria Belén, González, Marcos, Mateos, Maria Victoria, and Caballero, Maria Dolores

Abstract

The University Hospital of Salamanca, in Spain, had its first COVID-19 case on March 1st and as of May 11th, we had 1,100 positive cases. Based on the vulnerability of patients with blood cancers, on March 9th, the Hematology Department developed a protocol, amended as the new information was available, to maintain the Hematology Unit as a “free COVID-19 island.” The protocol included symptom-based surveys and screening tests to patients, caregivers, and healthcare personnel to identify early potential positive cases and prevent its spread. Between March 9 and April 28, 32 asymptomatic patients and caregivers were tested and 68 rT-PCR diagnostic assays have been performed with two positive results. A 106 healthcare workers have been tested (208 rT-PCR) and seven of them were positive. In summary, the implementation of preemptive measures after the first case appeared allowed us to be able to provide treatment to our patients.

Published
2020

24. Poster: MM-293: Early Relapse After Autologous Stem Cell Transplant in Multiple Myeloma: Single-Center Experience in Salamanca, Spain

Author

Borja Puertas-Martinez, Luz Gema Roman-Molano, Alejandro Avendaño-Pita, Noemi Puig-Moron, Sandra Patricia Gomez-Ubeda, Mónica Baile-González, Alberto Hernandez-Sanchez, Verónica González-de la Calle, Danylo Palomino-Mendoza, Sara Marcos Asensio, María Victoria Mateos-Manteca, Almudena Cabero-Martínez, and Felipe Peña-Muñoz

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Early Relapse, Hematology, medicine.disease, Single Center, Internal medicine, medicine, Stem cell, business, Multiple myeloma
Published
2021

25. MM-293: Early Relapse After Autologous Stem Cell Transplant in Multiple Myeloma: Single-Center Experience in Salamanca, Spain

Author

Felipe Peña-Muñoz, Luz Román-Molano, Danylo Palomino-Mendoza, Alberto Hernández-Sánchez, Borja Puertas-Martínez, Sandra Gómez-Úbeda, Mónica Baile-González, Almudena Cabero-Martínez, Alejandro Avendaño-Pita, Sara Marcos Asensio, Verónica González-de la Calle, Noemi Puig-Moron, and María Victoria Mateos-Manteca

Subjects
Cancer Research, Oncology, Hematology
Published
2021

26. Measures to Maintain a SARS-CoV-2 Negative Inpatient Hematological Unit in the Midst of the COVID-19 Pandemic

Author

Cabero-Martínez, Almudena, primary, Sánchez-Guijo, Fermín, additional, López-Corral, Lucía, additional, Pérez, Estefanía, additional, Avendaño, Alejandro, additional, Baile, Mónica, additional, Cabrero, Mónica, additional, Martín, Ana-Africa, additional, Rodríguez, Angela, additional, Pérez, Balbina, additional, Peña-Muñoz, Felipe, additional, Román, Luz-Gema, additional, Palomino, Danylo, additional, López-Vázquez, Lourdes, additional, Vidriales, María-Belén, additional, González-Diaz, Marcos, additional, Mateos, María-Victoria, additional, and Caballero, María-Dolores, additional

Published
2020
Full Text
View/download PDF

27. Post-Transplantation Cyclophosphamide Versus Low Doses ATG Fresenius As Part of Two Immunosuppression Regimens for Graft Versus Host Disease Prophylaxis: Low Severe Graft Versus Host Disease (GVHD) Incidence and y Similar Gvhd-Free and Relapse-Free Survival (GRFS)

Author

Fernández Martínez, Cristina, primary, Bermúdez, Arancha, additional, García Ávila, Sara, additional, San Pedro, Borja, additional, Cabero Martínez, Almudena, additional, Yáñez, Lucrecia, additional, López Duarte, Mónica, additional, Colorado, Mercedes, additional, González de Villambrosia, Sonia, additional, Mora, Joan Manuel, additional, Gonzalez Romero, Yolanda, additional, Gomez, David, additional, Fenandez Luis, Sara, additional, Ormazabal, Irati, additional, Insunza, Andrés, additional, Romon, Iñigo, additional, Arroyo, Jose Luis, additional, Conde, Eulogio, additional, and Richard, Carlos, additional

Published
2018
Full Text
View/download PDF

28. Very Low Dose of Anti-T-Lymphocyte Globulin Protects Against Severe Forms of Graft Versus Host Disease in High Risk Patients: The Experience in Our Center

Author

Mora, Joan Manuel, primary, Bermúdez, Arancha, additional, Cortés, Miguel Angel, additional, González Romero, Yolanda, additional, Colorado, Mercedes, additional, Fernández Martínez, Cristina, additional, Cabero Martínez, Almudena, additional, Gómez, David, additional, Fernández Luis, Sara, additional, García Ávila, Sara, additional, Yáñez, Lucrecia, additional, Ormazabal, Irati, additional, Martín Sánchez, Guillermo, additional, Arroyo, Jose Luis, additional, Núñez, Javier, additional, Romón, Iñigo, additional, Conde, Eulogio, additional, and Richard, Carlos, additional

Published
2018
Full Text
View/download PDF

29. Long-Term Results and Cost-Effectiveness of the Flagida-Lite Regimen in Elderly Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Author

Cabero Martínez, Almudena, Bermudez, Arancha, Yañez, Lucrecia, Insunza, Andrés, Colorado, Mercedes Araujo, Fernandez Martinez, Cristina, Martinez Callejo, Virginia, Bernal Del Castillo, Teresa, Sánchez Escamilla, Miriam, López Duarte, Mónica, Pérez Vázquez, German, Montes, Carmen, Conde, Eulogio, Gutiérrez, Maria Luisa, García Ávila, Sara, Celis, Mara, and Richard, Carlos

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results